Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Median Technologies

< Previous 1 2 3 Next >
Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
From Median Technologies
Via Business Wire
Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million
From Median Technologies
Via Business Wire
Median Technologies: Financial Communications Schedule for the First Half of 2023
From Median Technologies
Via Business Wire
Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations
From Median Technologies
Via Business Wire
Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter
From Median Technologies
Via Business Wire
Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening
From Median Technologies
Via Business Wire
Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®
From Median Technologies
Via Business Wire
Median Technologies: Financial Communication Schedule for the Second Half of 2022
From Median Technologies
Via Business Wire
Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022
From Median Technologies
Via Business Wire
Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy®
From Median Technologies
Via Business Wire
Median Technologies to host a live webcast and provide a company update on July 12, 2022
From Median Technologies
Via Business Wire
Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation
From Median Technologies
Via Business Wire
Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA
From Median Technologies
Via Business Wire
Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials
From Median Technologies
Via Business Wire
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
From Median Technologies
Via Business Wire
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
From Median Technologies
Via Business Wire
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
From Median Technologies
Via Business Wire
Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022
From Median Technologies
Via Business Wire
Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance
From Median Technologies
Via Business Wire
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million
From Median Technologies
Via Business Wire
Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy® Lung Cancer Screening
From Median Technologies
Via Business Wire
Median Technologies: Financial Communications Schedule for the First Half of 2022
From Median Technologies
Via Business Wire
Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization
From Median Technologies
Via Business Wire
Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators
From Median Technologies
Via Business Wire
Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021
From Median Technologies
Via Business Wire
Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications
From Median Technologies
Via Business Wire
Median Technologies Changes the Publication Date of Its H1 2021 Results
From Median Technologies
Via Business Wire
Median Technologies Announces Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 to Accurately Characterize Malignant vs Benign Lung Nodules Based on a Large-scale Patient Cohort
From Median Technologies
Via Business Wire
Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee
From Median Technologies
Via Business Wire
Median Technologies: Financial Communication Schedule for the Second Half Of 2021
From Median Technologies
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.